Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
Johnson & Johnson(JNJ) stock is priced at $239.50, giving the company a market capitalization of 577.16B. It carries a P/E multiple of 22.04 and pays a dividend yield of 2.1%.
During the trading session on 2026-03-17, Johnson & Johnson(JNJ) shares reached a daily high of $244.00 and a low of $239.18. At a current price of $239.50, the stock is +0.1% higher than the low and still -1.8% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 2.69M, versus its average volume of 7.22M.
The stock's 52-week range extends from a low of $141.50 to a high of $251.71.
The stock's 52-week range extends from a low of $141.50 to a high of $251.71.
JNJ News
In early trading on Tuesday, shares of Goldman Sachs Group topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.8%...
UBS analyst Danielle Antalffy raised the firm’s price target on Johnson & Johnson to $280 from $245 and keeps a Buy rating on the shares. Published first on Th...
Due to the "big, beautiful bill" passed last year, many taxpayers can expect a larger refund from the Internal Revenue Service this tax season. That's because t...
Analyst ratings
59%
of 29 ratingsMore JNJ News
Johnson & Johnson announced results from an open-label, multicenter Phase 1 study evaluating an investigational intravesical drug-releasing system with erdafiti...
Monte Rosa Therapeutics (GLUE) announced the company has entered into a supply agreement with Johnson & Johnson to evaluate MRT-2359 in combination with ERLEADA...
Johnson & Johnson (NYSE:JNJ) reported strong Phase 1 results for its intravesical erdafitinib drug releasing system in non muscle invasive bladder cancer. The...
(RTTNews) - Johnson & Johnson (JNJ) announced new data from an open-label, multicenter Phase 1 study evaluating Erda-iDRS, an investigational intravesical drug-...
Johnson & Johnson announced results from an open-label, multicenter Phase 1 study evaluating an investigational intravesical drug-releasing system with erdafiti...
Wondering whether Johnson & Johnson is fairly priced at its current level, or if the market is missing something in this healthcare giant's story? The stock re...
Dividend investing is a proven way to grow your wealth over the long run. But for the strategy to work, investors need to pick quality income stocks, those with...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.